Sculptor Capital’s Bristol-Myers Squibb BMY Stock Holding History

Sculptor Capital’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q1	–	Sell	-907,300	Closed	-$53.6M	–	458
2014 Q4	$53.6M	Buy	907,300 +100,000	+12%	+$5.64M	0.14%	138
2014 Q3	$41.3M	Hold	807,300	–	–	0.12%	162
2014 Q2	$39.2M	Hold	807,300	–	–	0.12%	176
2014 Q1	$41.9M	Sell	807,300 -1,318,000	-62%	-$70.1M	0.14%	156
2013 Q4	$113M	Sell	2,125,300 -17,100	-0.8%	-$871K	0.29%	102
2013 Q3	$99.2M	Sell	2,142,400 -344,500	-14%	-$15.1M	0.28%	105
2013 Q2	$111M	Buy	+2,486,900	New	+$108M	0.35%	84

Other funds holding BMY

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Sculptor Capital's BMY Position: Q3 2022 in Review

Sculptor Capital sold out of Bristol-Myers Squibb (BMY) in Q3 2022, closing a stake of 108,809 shares — an estimated $8.38M sold.

Sculptor Capital first reported a position in BMY in Q4 2013 and held it in 8 quarters. The position peaked at $77.2M in Q4 2016. 2,472 funds tracked by Wall St. Rank hold BMY as of Q3 2022.

Sculptor Capital reported no remaining Bristol-Myers Squibb position as of Q3 2022 after selling out during the quarter.
Sculptor Capital sold 108,809 Bristol-Myers Squibb shares in Q3 2022, an estimated $8.38M.
Sculptor Capital first reported a position in Bristol-Myers Squibb in Q4 2013 and held it in 8 quarters.
Sculptor Capital's Bristol-Myers Squibb position peaked at $77.2M in Q4 2016.
2,472 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q3 2022.

Based on Sculptor Capital's 13F filing for Q3 2022, filed 14 Nov 2022.